日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies

重症肌无力患者对efgartigimod治疗反应的异质性：预测因素和治疗策略

期刊:Neurotherapeutics
影响因子:
doi:10.1016/j.neurot.2026.e00837
Fuchs, Lior; Vigiser, Ifat; Kolb, Hadar; Regev, Keren; Drory, Vivian E; Dori, Amir; Magalashvili, David; Caller, Tal; Kenan, Gilad; Mechnik Steen, Yana; Hellmann, Mark; Wilf-Yarkoni, Adi; Friedman Korn, Tal; Vaknin-Dembinsky, Adi; Bsoul, Alaa; Shelly, Shahar; Karni, Arnon
重症肌无力
免疫/内分泌
发表日期：2026
文献求助 收藏

Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter Study

Susac综合征的临床特征和预后危险因素：一项回顾性多中心研究

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000200357
Fuchs, Lior; Wilf-Yarkoni, Adi; Kolb, Hadar; Vigiser, Ifat; Regev, Keren; Zur, Dinah; Habot-Wilner, Zohar; Oron, Yahav; Furer, Viktoria; Shimon, Nitai; Hellmann, Mark A; Lotan, Itay; Auriel, Eitan; Rennebohm, Robert; Elkayam, Ori; Karni, Arnon
发表日期：2025
文献求助 收藏

Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis

视神经脊髓炎谱系疾病和多发性硬化症中，视神经炎后视网膜变性与视网膜高反射灶相关。

期刊:European Journal of Neurology
影响因子:3.9
doi:10.1111/ene.70038
Klyscz, Philipp; Vigiser, Ifat; Solorza Buenrostro, Gilberto; Motamedi, Seyedamirhosein; Leutloff, Carla Johanna; Schindler, Patrick; Schmitz-Hübsch, Tanja; Paul, Friedemann; Zimmermann, Hanna Gwendolyn; Oertel, Frederike Cosima
神经科学
多发性硬化症
发表日期：2025
文献求助 收藏

BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves

在α波、δ波和ω波期间，BNT162b2 mRNA COVID-19疫苗三剂接种方案对重症肌无力患者感染COVID-19的风险及安全性研究

期刊:Journal of Neurology
影响因子:4.6
doi:10.1007/s00415-022-11303-8
Doron, Alon; Piura, Yoav; Vigiser, Ifat; Kolb, Hadar; Regev, Keren; Nesher, Nahum; Karni, Arnon
炎症/感染
重症肌无力
免疫/内分泌
发表日期：2022
文献求助 收藏

Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study

以色列阿什肯纳兹犹太患者和非阿什肯纳兹犹太患者多发性硬化症临床和流行病学特征的差异：一项回顾性单中心研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-08565-7
Karni, Arnon; Ben Noon, Gil; Shiner, Tamara; Vigiser, Ifat; Kolb, Hadar; Regev, Keren
神经科学
多发性硬化症
发表日期：2022
文献求助 收藏

JCV seroconversion rate during the SARS COVID-19 pandemic

SARS-CoV-19大流行期间JCV血清转化率

期刊:Multiple Sclerosis and Related Disorders
影响因子:2.9
doi:10.1016/j.msard.2022.104244
Vigiser, I; Piura, Y; Kolb, H; Shiner, T; Komarov, I; Karni, A; Regev, K
发表日期：2022
文献求助 收藏

Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation

复发缓解型多发性硬化症患者免疫细胞中 Ephrins 表达增加影响少突胶质细胞分化

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms22042182
Maya Golan, Avivit Krivitsky, Karin Mausner-Fainberg, Moshe Benhamou, Ifat Vigiser, Keren Regev, Hadar Kolb, Arnon Karni
免疫
神经
多发性硬化症
胶质细胞
发表日期：2021
文献求助 收藏

The yield of immediate post lung biopsy CT in predicting iatrogenic pneumothorax

肺活检后即刻CT检查在预测医源性气胸中的应用价值

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-020-1128-8
Brzezinski, Rafael Y; Vigiser, Ifat; Fomin, Irina; Israeli, Lilach; Shenhar-Tsarfaty, Shani; Bar-Shai, Amir
发表日期：2020
文献求助 收藏